Canada markets closed
  • S&P/TSX

    18,125.72
    -194.95 (-1.06%)
     
  • S&P 500

    3,768.47
    -51.25 (-1.34%)
     
  • DOW

    30,924.14
    -345.95 (-1.11%)
     
  • CAD/USD

    0.7898
    -0.0006 (-0.07%)
     
  • CRUDE OIL

    64.03
    +2.75 (+4.49%)
     
  • BTC-CAD

    61,127.21
    -3,791.76 (-5.84%)
     
  • CMC Crypto 200

    967.12
    -20.09 (-2.04%)
     
  • GOLD FUTURES

    1,694.90
    -20.90 (-1.22%)
     
  • RUSSELL 2000

    2,146.92
    -60.87 (-2.76%)
     
  • 10-Yr Bond

    1.5500
    +0.0800 (+5.44%)
     
  • NASDAQ futures

    12,432.00
    -249.75 (-1.97%)
     
  • VOLATILITY

    28.57
    +1.90 (+7.12%)
     
  • FTSE

    6,650.88
    -24.59 (-0.37%)
     
  • NIKKEI 225

    28,930.11
    -628.99 (-2.13%)
     
  • CAD/EUR

    0.6594
    +0.0047 (+0.72%)
     

CDC panel meets Tuesday to vote on COVID-19 vaccine priority

·1 min read
FILE - In this Monday, March 16, 2020 file photo, Neal Browning receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus at the Kaiser Permanente Washington Health Research Institute in Seattle. A panel of U.S. advisers will meet this week to recommend who should be first in line for a COVID-19 vaccine. Experts have proposed giving the vaccine to health workers first. High priority also may be given to workers in essential industries, people with certain medical conditions and people age 65 and older. (AP Photo/Ted S. Warren, File)

ATLANTA (AP) — A panel of U.S. advisers will meet Tuesday to vote on how scarce, initial supplies of a COVID-19 vaccine will be given out once one has been approved.

Experts have proposed giving the vaccine to health workers first. High priority also may be given to workers in essential industries, people with certain medical conditions and people age 65 and older.

Tuesday's meeting is for the Advisory Committee on Immunization Practices, a group established by the Centers for Disease Control and Prevention. The panel of experts recommends who to vaccinate and when -- advice that the government almost always follows. The agenda for next week's emergency meeting was posted Friday.

Pfizer and its German partner BioNTech have asked the Food and Drug Administration to allow emergency use of its COVID-19 vaccine candidate. Moderna Inc. is expected to also seek emergency use of its vaccine soon.

FDA's scientific advisers are holding a public meeting Dec. 10 to review Pfizer's request, and send a recommendation to the FDA.

Manufacturers already have begun stockpiling coronavirus vaccine doses in anticipation of eventual approval, but the first shots will be in short supply and rationed.